HK1172691A1 - Methods and compositions for diagnosis and prognosis of renal injury and renal failure - Google Patents

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Info

Publication number
HK1172691A1
HK1172691A1 HK12113504.8A HK12113504A HK1172691A1 HK 1172691 A1 HK1172691 A1 HK 1172691A1 HK 12113504 A HK12113504 A HK 12113504A HK 1172691 A1 HK1172691 A1 HK 1172691A1
Authority
HK
Hong Kong
Prior art keywords
renal
prognosis
diagnosis
compositions
methods
Prior art date
Application number
HK12113504.8A
Other languages
English (en)
Chinese (zh)
Inventor
‧安德貝里
．格雷
．麥克弗森
．中村
．坎普夫
Original Assignee
阿斯圖特醫藥公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 阿斯圖特醫藥公司 filed Critical 阿斯圖特醫藥公司
Publication of HK1172691A1 publication Critical patent/HK1172691A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4748—Details p53
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK12113504.8A 2009-08-28 2012-12-28 Methods and compositions for diagnosis and prognosis of renal injury and renal failure HK1172691A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US23812309P 2009-08-28 2009-08-28
US23812809P 2009-08-28 2009-08-28
US23812509P 2009-08-28 2009-08-28
US23812109P 2009-08-28 2009-08-28
US23812909P 2009-08-28 2009-08-28
US23811509P 2009-08-28 2009-08-28
US23811809P 2009-08-28 2009-08-28
US23812709P 2009-08-28 2009-08-28
US23813409P 2009-08-28 2009-08-28
US23812009P 2009-08-28 2009-08-28
US24399309P 2009-09-18 2009-09-18
US24399709P 2009-09-18 2009-09-18
US24399109P 2009-09-18 2009-09-18
US24400209P 2009-09-18 2009-09-18
PCT/US2010/046910 WO2011025917A1 (fr) 2009-08-28 2010-08-27 Procédés et compositions pour le diagnostic et le pronostic d'une lésion rénale et d'une insuffisance rénale

Publications (1)

Publication Number Publication Date
HK1172691A1 true HK1172691A1 (en) 2013-04-26

Family

ID=43628398

Family Applications (2)

Application Number Title Priority Date Filing Date
HK12113504.8A HK1172691A1 (en) 2009-08-28 2012-12-28 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK15108654.3A HK1208074A1 (en) 2009-08-28 2015-09-04 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15108654.3A HK1208074A1 (en) 2009-08-28 2015-09-04 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Country Status (9)

Country Link
US (2) US20120315649A1 (fr)
EP (3) EP2894473B1 (fr)
JP (2) JP5775874B2 (fr)
CN (2) CN104483488A (fr)
AU (1) AU2010286559B2 (fr)
CA (1) CA2772336A1 (fr)
HK (2) HK1172691A1 (fr)
NZ (2) NZ624609A (fr)
WO (1) WO2011025917A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011075744A1 (fr) 2009-12-20 2011-06-23 Astute Medical, Inc. Procédés et compositions pour diagnostic et pronostic d'une lésion rénale et d'une insuffisance rénale
KR101940014B1 (ko) 2010-02-05 2019-01-21 아스튜트 메디컬 인코포레이티드 신손상 및 신부전을 진단 및 예측하는 방법 및 조성물
CA2803500A1 (fr) * 2010-06-23 2011-12-29 Astute Medical, Inc. Methodes et compositions pour diagnostiquer et pronostiquer une lesion renale et une insuffisance renale
EP3339859A1 (fr) 2010-06-23 2018-06-27 Astute Medical, Inc. Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et d'insuffisance rénale
US10557856B2 (en) 2010-09-24 2020-02-11 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Biomarkers of renal injury
WO2012102963A1 (fr) * 2011-01-26 2012-08-02 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Biomarqueurs urinaires pour prédire la guérison après une lésion rénale aiguë : protéomique
EP2503340A1 (fr) * 2011-03-22 2012-09-26 Fundació Institut de Recerca Hospital Universitari Vall d'Hebron, Fundació Privada Marqueur de diagnostic pour la rechute de la glomérulosclérose segmentaire focale idiopathique primaire
TW201250248A (en) * 2011-04-25 2012-12-16 Kyowa Medex Co Ltd Prognostication method of renal failure
EP2707524A4 (fr) * 2011-05-12 2015-05-06 Astute Medical Inc Méthodes et compositions utilisées pour le diagnostic et le pronostic de l'atteinte rénale et de l'insuffisance rénale
EP3540440B1 (fr) 2011-12-08 2022-09-28 Astute Medical, Inc. Procédés et utilisations pour l'évaluation des lésions rénales et du statut rénal
ES2794448T3 (es) * 2012-04-02 2020-11-18 Astute Medical Inc Procedimientos para el diagnóstico y pronóstico de sepsis
WO2014113558A1 (fr) * 2013-01-17 2014-07-24 Astute Medical, Inc. Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et d'insuffisance rénale
CN104569417B (zh) * 2013-10-12 2016-06-01 广州瑞博奥生物科技有限公司 一种用于早期诊断急性肾损伤的抗体芯片试剂盒
WO2015084939A1 (fr) 2013-12-03 2015-06-11 Astute Medical, Inc. Méthodes et compositions de diagnostic et de pronostic de lésion rénale et d'insuffisance rénale
EP3281011B1 (fr) 2015-04-09 2024-06-05 Astute Medical, Inc. Méthodes et compositions pour le diagnostic et le pronostic d'une lésion rénale et d'une insuffisance rénale
WO2016183377A1 (fr) 2015-05-12 2016-11-17 Astute Medical, Inc. Procédés et compositions pour le diagnostic et le pronostic d'une lésion rénale et d'une insuffisance rénale
WO2017214203A1 (fr) 2016-06-06 2017-12-14 Astute Medical, Inc. Prise en charge de lésions rénales aiguës au moyen de la protéine de liaison de facteur de croissance insulinomimétique 7 et de l'inhibiteur tissulaire de métalloprotéinase 2
JP2021526221A (ja) 2018-05-24 2021-09-30 レニバス・セラピューティクス・インコーポレイテッド 腎障害及び腎不全のリスクのある患者を治療する方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
WO1992005282A1 (fr) 1990-09-14 1992-04-02 Biosite Diagnostics, Inc. Anticorps contre des complexes de recepteurs de ligand et des ligands ainsi que leur utilite dans des dosages ligands-recepteurs
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
AU1911592A (en) 1991-04-10 1992-11-17 Biosite Diagnostics Incorporated Novel conjugates and assays for simultaneous detection of multiple ligands
CA2107894C (fr) 1991-04-10 2003-10-14 Kenneth F. Buechler Subtances inhibitrices
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
CA2356174A1 (fr) * 1998-12-21 2000-06-29 Monash University Detection et traitement de maladies du rein
WO2002048329A2 (fr) * 2000-11-20 2002-06-20 Idun Pharmaceuticals, Inc. Caspase 3 derivee d'une membrane, compositions contenant cette caspase et procedes d'utilisation associes
WO2002081515A1 (fr) * 2001-04-03 2002-10-17 Kyowa Hakko Kogyo Co., Ltd. Proteine de liaison de facteur de croissance de type insuline
US20030003588A1 (en) * 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
DE602004022150D1 (de) * 2003-03-27 2009-09-03 Childrens Hosp Medical Center Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung
CN1791797A (zh) * 2003-03-27 2006-06-21 儿童医院医疗中心 用于检测肾小管细胞损伤的早发的方法和试剂盒
US7416854B2 (en) * 2004-01-22 2008-08-26 Promega Corporation Luminogenic and nonluminogenic multiplex assay
US20090215046A1 (en) * 2004-01-27 2009-08-27 Compugen Ltd. Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
CA2580126C (fr) * 2004-09-28 2014-08-26 Quark Biotech, Inc. Oligoribonucleotides et procedes d'utilisation associes pour le traitement de l'alopecie, des insuffisances renales aigues et d'autres maladies
US7141382B1 (en) * 2004-10-12 2006-11-28 Parikh Chirag R Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality
ES2336345T3 (es) * 2004-12-20 2010-04-12 Antibodyshop A/S Determinacion de lipocalina asociada a gelatinasa de neutrofilos (ngal) como marcador de diagnostico para trastornos renales.
WO2006102979A2 (fr) * 2005-03-31 2006-10-05 Johannes Gutenberg-Universität Mainz Marqueurs d'inflammation et combinaisons de ces marqueurs en tant que marqueurs biochimiques pour des maladies cardio-vasculaires
WO2006116622A2 (fr) * 2005-04-27 2006-11-02 Emiliem Nouveaux procedes et dispositifs d'evaluation de substances toxiques
TW200716764A (en) * 2005-05-02 2007-05-01 Genenews Inc Bladder cancer biomarkers and uses thereof
ATE510929T1 (de) * 2005-06-08 2011-06-15 Hitachi Chemical Res Ct Inc Verfahren zur vorhersage einer immunantwort auf eine tumorerkrankung auf der grundlage eines mrna-expressionsprofils in tumorzellen und stimulierten leukozyten
US7662578B2 (en) * 2006-04-21 2010-02-16 Children's Hospital Medical Center Method and kit for the early detection of impaired renal status
WO2007121495A2 (fr) * 2006-04-24 2007-11-01 Medizinische Universität Wien Procédé de diagnostic de maladies cardiovasculaires
PL2115477T3 (pl) * 2007-01-25 2015-12-31 Hoffmann La Roche Zastosowanie IGFBP-7 do oceny niewydolności serca
WO2008122670A2 (fr) * 2007-04-10 2008-10-16 Integragen Gène tnfrsf10b de susceptibilité au diabète chez l'homme
US20110183434A1 (en) * 2008-01-17 2011-07-28 Myles Wolf Diagnostic methods and kits using fibroblast growth factor-23
CN102246038B (zh) * 2008-10-21 2014-06-18 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物

Also Published As

Publication number Publication date
AU2010286559A1 (en) 2012-04-05
JP5775874B2 (ja) 2015-09-09
EP2894473B1 (fr) 2016-09-21
EP2470905A1 (fr) 2012-07-04
JP2013503344A (ja) 2013-01-31
NZ624609A (en) 2015-12-24
EP2894473A1 (fr) 2015-07-15
WO2011025917A1 (fr) 2011-03-03
JP2015212704A (ja) 2015-11-26
EP2470905B1 (fr) 2015-01-07
HK1208074A1 (en) 2016-02-19
NZ598712A (en) 2014-05-30
CN102792161A (zh) 2012-11-21
JP6054481B2 (ja) 2016-12-27
EP3151005A1 (fr) 2017-04-05
AU2010286559B2 (en) 2015-01-22
US20150204892A1 (en) 2015-07-23
CN102792161B (zh) 2014-11-12
US20120315649A1 (en) 2012-12-13
CA2772336A1 (fr) 2011-03-03
EP2470905A4 (fr) 2013-08-14
CN104483488A (zh) 2015-04-01

Similar Documents

Publication Publication Date Title
HK1211082A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1212776A1 (zh) 用於診斷和預後腎損傷和腎衰竭的方法和組合物
HK1213320A1 (zh) 用於診斷和預後腎損傷和腎衰竭的方法和組合物
EP2480882A4 (fr) Procedes et compositions de diagnostic et de pronostic de lesions et d'insuffisances renales
HK1203619A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1208074A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1199929A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1167455A1 (zh) 用於腎損傷和腎衰竭的診斷及預後方法和組合物
HK1199931A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1159755A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2539712A4 (fr) Procédés et compositions pour diagnostic et pronostic de lésion rénale et d'insuffisance rénale
HK1214864A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
EP2531620A4 (fr) Méthodes et compositions utilisables pour le diagnostic et le pronostic d'une lésion rénale et d'une insuffisance rénale
HK1200218A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1167888A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1211084A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1212770A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
HK1212774A1 (zh) 用於腎損傷和腎衰竭的診斷及預後方法和組合物
EP2462446A4 (fr) Méthodes et compositions utilisables à des fins de diagnostic et de pronostic en cas de lésion ou d'insuffisance rénale
EP2585825A4 (fr) Méthodes et compositions pour diagnostiquer et pronostiquer une lésion rénale et une insuffisance rénale
EP2593794A4 (fr) Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et d'insuffisance rénale
HK1197298A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200830